欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可持有人/公司名称	上市批准日期	授权状态
Symtuza	Human	darunavir, cobicistat, emtricitabine, tenofovir alafenamide	darunavir, cobicistat, emtricitabine, tenofovir alafenamide	EMEA/H/C/004391	Janssen-Cilag International NV	2017/09/21	Authorised
Genvoya	Human	elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide	elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide	EMEA/H/C/004042	Gilead Sciences Ireland UC	2015/11/19	Authorised
Evotaz	Human	atazanavir, cobicistat	cobicistat, atazanavir	EMEA/H/C/003904	Bristol-Myers Squibb Pharma EEIG	2015/07/13	Authorised
Rezolsta	Human	darunavir, cobicistat	darunavir, cobicistat	EMEA/H/C/002819	Janssen-Cilag International N.V.	2014/11/19	Authorised
Tybost	Human	cobicistat	cobicistat	EMEA/H/C/002572	Gilead Sciences Ireland UC	2013/09/19	Authorised
Stribild	Human	elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil	elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate	EMEA/H/C/002574	Gilead Sciences Ireland UC	2013/05/24	Authorised

药品名称Medicine name	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号Product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可持有人/公司名称Marketing authorisation holder/company name	*示例：Janssen
人用药物治疗分组Human pharmacotherapeutic group	*示例：Antineoplastic
适应症Condition / indication	*示例：leukaemia
授权状态Authorisation status
上市批准日期Marketing authorisation date	-